AbbVie實時圖表

金融工具基礎知識

Weekly Search
Weekly
Daily
日期 關閉 更改 更改(%): 開倉

最新新聞

Frances Wang 2025 Apr 22, 16:00

歐洲央行會降息嗎?利率如何影響債券市場?

Frances Wang 2025 Apr 22, 16:00

關稅新聞:亞洲市場上漲,日元因關稅談判下跌

Frances Wang 2025 Apr 22, 16:00

今日AMD股價:影響AMD股價的因素

Frances Wang 2025 Apr 21, 16:00

今日股市:道瓊斯、標普500和納斯達克因特朗普批評聯邦儲備主席鮑威爾而下跌

Frances Wang 2025 Apr 21, 16:00

亞洲股市指數:恆生指數下跌,日經225指數下滑,印度Sensex上漲

Frances Wang 2025 Apr 21, 16:00

今日金價:XAUUSD超過3,400美元,面對關稅不確定性

Frances Wang 2025 Apr 21, 16:00

今日外匯市場:美元跌至三年低點,USD/CHF接近0.8102

Frances Wang 2025 Apr 20, 16:00

現在值得考慮的股票:Nu股票是一個好選擇嗎?

聯絡方式

點差

1.13

點差(%)

0.6396 %

槓桿

1:10

隔夜利息(買入)

-0.0597 %

隔夜利息(賣出)

-0.0292 %

貨幣

USD

交易時間

市場關閉

星期四

13:31 - 19:59

星期一

13:31-19:59

星期二

13:31-19:59

星期三

13:31-19:59

星期五

13:31-19:59

分析與統計

開倉

---

上一次平倉

---

52 週高點/低點

--- – ---

市值

307413352448

流通股份

1768979968

收益日期(下一個)

0000-00-00

現金殖利率 

2025-05-15

除息日

2025-04-15

遠期年股息率

6.56

遠期年現金殖利率

0.0377

每股盈餘

2.4

了解有關此金融工具的詳細資訊

AbbVie AbbVie Inc
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta/Venclyxto to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic to treat neurologic diseases; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duopa and Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; and Qulipta for episodic and chronic migraine, as well as other neuroscience products. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

相關工具

資產
出售
購買
更改(%):
查看所有金融工具
Trustpilot